Acute cor pulmonale from saddle pulmonary embolism in a patient with previous COVID-19: should we prolong prophylactic anticoagulation?

Severe coronavirus disease 2019 (COVID-19) is known to be associated with a heightened risk of thromboembolism. However, the risk associated with mild and moderate illness from COVID-19 is unknown, and there is no current recommendation for prophylaxis against thromboembolism in patients after hospital treatment, unless there are established thrombophilic risk factors. We report the case of a 52-year-old woman who presented with massive saddle pulmonary embolism 1 week after initial hospital discharge, which was treated successfully with thrombolysis. This case raises the question of whether extended prophylactic anticoagulation should be considered even in low-risk COVID-19 cases..

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:97

Enthalten in:

International Journal of Infectious Diseases - 97(2020), Seite 299-302

Sprache:

Englisch

Beteiligte Personen:

Sadaf Ali [VerfasserIn]
Smitha Mathew [VerfasserIn]
Joseph M. Pappachan [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.sciencedirect.com [kostenfrei]
Journal toc [kostenfrei]

Themen:

COVID-19
Infectious and parasitic diseases
Prophylactic anticoagulation
Thromboembolism

doi:

10.1016/j.ijid.2020.06.039

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ007705670